Skip to main content
Equibles
CHE logo

CHE · Chemed Corp · Webcasts, Transcripts & Audio

Track CHE — free

Use CHE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CHE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$502.90 -2.17 (-0.43%) At close · Oct 1
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$6.70B
Shares
13.07M
Volume · Oct 1 201.69K Avg daily vol (3M) 160.95K

Chemed Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Chemed Corp (CHE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼2.3% $526.47M $56.87M '22 Q3 22-10-31 ▲1% $546.65M $62.13M '22 Q4 23-02-23 ▲5.6% $560.16M $54.12M '23 Q1 23-04-26 ▲4.2% $553.82M $53.38M '23 Q2 23-07-26 ▲7.2% $564.53M $74.96M '23 Q3 23-10-25 ▲7.2% $585.91M $90.05M '23 Q4 24-02-27 ▲5.2% $589.23M $65.02M '24 Q1 24-04-24 ▲7.6% $595.88M $70.89M '24 Q2 24-07-24 ▲7.4% $606.18M $75.78M '24 Q3 24-10-29 ▲9.2% $639.99M $90.32M '24 Q4 25-02-26 ▲9.8% $646.94M $71.76M '25 Q1 25-04-23 ▲3.8% $618.80M $52.49M '25 Q2 25-07-30 ▲3.1% $624.90M $64.24M '25 Q3 25-10-29 ▼0.1% $639.34M $76.75M '25 Q4 26-02-26 ▲1.6% $657.51M $66.30M '26 Q1 26-04-24 LATEST ▲8.8% $673.25M $67.70M '26 Q2 26-07-29
Earnings call
FY26 · Q2
2026-07-29
Chemed Corp (CHE) Q2 2026 Earnings Call Transcript
Confident tone VITAS hospice admissions growth Florida Medicare cap position Roto-Rooter commercial business
Revenue
$673.25M
▲ 8.8% YoY
Diluted EPS
$5.13
▲ 43.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-24
Chemed Corp (CHE) Q1 2026 Earnings Call Transcript
Confident tone VITAS admissions and patient mix VITAS regulatory and fraud concerns Florida Medicare cap position
Revenue
$657.51M
▲ 1.6% YoY
Diluted EPS
$4.84
▼ 0.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Chemed Corp (CHE) Q4 2025 Earnings Call Transcript
Positive tone Paid vs. natural search leads VITAS admissions mix rebalancing Water restoration billing and collections
Revenue
$639.34M*
▼ 0.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Chemed Corp (CHE) Q3 2025 Earnings Call Transcript
Positive tone VITAS Medicare Cap mitigation Lead generation mix shift VITAS admissions and census growth
Revenue
$624.90M
▲ 3.1% YoY
Diluted EPS
$4.46
▼ 10.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Chemed Corp (CHE) Q2 2025 Earnings Call Transcript
Cautious tone VITAS Medicare cap / Florida billing limitation VITAS admissions and patient mix Roto-Rooter competition and marketing
Revenue
$618.80M
▲ 3.8% YoY
Diluted EPS
$3.57
▼ 23.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Chemed Corp (CHE) Q1 2025 Earnings Call Transcript
Confident tone VITAS operating performance and growth Roto Rooter revenue and margin trends Medicare cap management
Revenue
$646.94M
▲ 9.8% YoY
Diluted EPS
$4.86
▲ 14.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Chemed Corp (CHE) Q4 2024 Earnings Call Transcript
Positive tone VITAS Healthcare operations Medicare cap limitations 2025 financial guidance
Revenue
$639.99M*
▲ 9.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Chemed Corp (CHE) Q3 2024 Earnings Call Transcript
Balanced tone Roto-Rooter revenue decline VITAS Healthcare strong performance 2025 outlook and guidance
Revenue
$606.18M
▲ 7.4% YoY
Diluted EPS
$5.00
▲ 1.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Chemed Corp (CHE) Q2 2024 Earnings Call Transcript
Confident tone Florida Market Expansion (CON) Covenant Health Acquisition VITAS Hospice Operating Strength
Revenue
$595.88M
▲ 7.6% YoY
Diluted EPS
$4.65
▲ 32.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript
Positive tone VITAS admissions and census growth VITAS hiring and retention Covenant Health and Community Services acquisition
Revenue
$589.23M
▲ 5.2% YoY
Diluted EPS
$4.24
▲ 18.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Chemed Corp (CHE) Q4 2023 Earnings Call Transcript
Positive tone VITAS operational improvement and ADC growth 2024 guidance and margin outlook Medicare reimbursement dynamics
Revenue
$585.91M*
▲ 7.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Chemed Corp (CHE) Q3 2023 Earnings Call Transcript
Revenue
$564.53M
▲ 7.2% YoY
Diluted EPS
$4.93
▲ 30.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Chemed Corp (CHE) Q2 2023 Earnings Call Transcript
Revenue
$553.82M
▲ 4.2% YoY
Diluted EPS
$3.51
▼ 20.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Chemed Corp (CHE) Q1 2023 Earnings Call Transcript
Revenue
$560.16M
▲ 5.6% YoY
Diluted EPS
$3.58
▼ 15.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Chemed Corp (CHE) Q4 2022 Earnings Call Transcript
Revenue
$546.65M*
▲ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-31
Chemed Corp (CHE) Q3 2022 Earnings Call Transcript
Revenue
$526.47M
▼ 2.3% YoY
Diluted EPS
$3.78
▼ 16.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Chemed Corp (CHE) Q2 2022 Earnings Call Transcript
Revenue
$531.29M
▼ 0.2% YoY
Diluted EPS
$4.40
▲ 25.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-26
Chemed Corp (CHE) Q1 2022 Earnings Call Transcript
Revenue
$530.55M
▲ 0.6% YoY
Diluted EPS
$4.22
▲ 5.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Chemed Corp (CHE) Q4 2021 Earnings Call Transcript
Revenue
$540.98M*
▲ 1.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Chemed Corp (CHE) Q3 2021 Earnings Call Transcript
Revenue
$538.67M
▲ 2% YoY
Diluted EPS
$4.55
▲ 9.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Chemed Corp (CHE) Q2 2021 Earnings Call Transcript
Revenue
$532.26M
▲ 6% YoY
Diluted EPS
$3.51
▼ 29.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Chemed Corp (CHE) Q1 2021 Earnings Call Transcript
Revenue
$527.36M
▲ 2.2% YoY
Diluted EPS
$4.01
▲ 18.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Chemed Corp (CHE) Q4 2020 Earnings Call Transcript
Revenue
$533.29M*
▲ 2.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Chemed Corp (CHE) Q3 2020 Earnings Call Transcript
Revenue
$528.30M
▲ 9.9% YoY
Diluted EPS
$4.14
▲ 16.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Chemed Corp (CHE) Q2 2020 Earnings Call Transcript
Revenue
$502.20M
▲ 6% YoY
Diluted EPS
$5.01
▲ 62.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Chemed Corp (CHE) Q1 2020 Earnings Call Transcript
Revenue
$515.80M
▲ 11.6% YoY
Diluted EPS
$3.38
▲ 25.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-18
Chemed Corp (CHE) Q4 2019 Earnings Call
Revenue
$522.32M*
▲ 14.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 19584 CUSIP 16359R103 13F (30d) 16 filings 12 filers Visit website Investor relations